Polio

Recent News

May 07, 2021

News Scan for May 07, 2021

High global COVID deaths
Obesity and severe COVID-19
Polio in 2 countries
Boost in monkeypox-smallpox vaccine supply
Apr 30, 2021

News Scan for Apr 30, 2021

Maternal COVID and infant outcomes
Nasopharyngeal swab complications
Flu vaccine nudges
Polio in 9 countries
Apr 16, 2021

News Scan for Apr 16, 2021

Antibiotic use in re-hospitalized MRSA patients
H1N1v flu case in Wisconsin
Polio in 10 countries
Apr 09, 2021

News Scan for Apr 09, 2021

H5 flu infections in Nigeria
H5N6 avian flu case in Laos
Polio in 3 countries
Apr 02, 2021

News Scan for Apr 02, 2021

Salmonella outbreak tied to songbirds
Ebola case in Guinea
Polio in 2 countries
Mar 30, 2021

News Scan for Mar 30, 2021

COVID-19 and social vulnerability
CARB-X funds for gonorrhea vaccine
Polio vaccinator killings
Avian flu in 2 nations
Mar 29, 2021

News Scan for Mar 29, 2021

Young adults and COVID-19
Pre-symptomatic COVID spread
Vaccine-derived polio rise
Mar 26, 2021

News Scan for Mar 26, 2021

Long COVID-19 in women
Pandemic PPE shortages
North Carolina H1N1v flu case
Polio in 2 countries
Mar 19, 2021

News Scan for Mar 19, 2021

Wisconsin CWD cull
Call for more federal AMR funds
Global antibiotic stewardship efforts
Polio in 3 countries
Mar 12, 2021

News Scan for Mar 12, 2021

Grants for phage research
Guinea Ebola source
Multistate E coli outbreak
More polio in 6 nations

Resources & Literature

Recent Literature

Ahmad M, Verma H, Kunwar A, et al. Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016. Int J Infect Dis 2020 (published online Oct 29)

Alamo-Junquer D, Politi J, Simon P, et al. Coordinated response to imported vaccine-derived poliovirus infection, Barcelona, Spain, 2019-2020. Emerg Infect Dis (Dispatch) 2021 May;27(5)

Anderson A, Fisker AB, Nielsen S, et al. National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: An analysis of 13 years of demographic surveillance data from an urban African area. Clin Infect Dis 2020 (published online Sep 19)

Bandyopadhyay AS, Gast C, Rivera L, et al. Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial. Lancet Infect Dis 2020 (published online Oct 23)

Bullo UF, Mehraj J, Raza SM, et al. An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan. BMC Med 2021 Jan 6;21(44)

Chard AN, Datta SD, Tallis G, et al. Progress toward polio eradication—worldwide, January 2019–March 2020. MMWR 2020 Jun 26;69(25):784-9

De Coster I, Leroux-Roels I, Bandyopadhyay AS, et al. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. Lancet 2020 (published online Dec 9)

Global poliovirus risk management and modeling. Risk Anal 2021 Feb 15:223-406

Jiang R, Liu X, Sun X, et al. Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population. Vaccine 2021 (published online Jan 22)

Joffret JL, Dote JW, Gumede N, et al. Vaccine-derived polioviruses, Central African Republic, 2019. Emerg Infect Dis 2021 Feb;27(2)

Kalkowska DA, Pallansch MA, Cochi SL, et al. Updated characterization of poliovirus transmission in Pakistan and Afghanistan and the impacts of different outbreak response vaccine options. J Infect Dis 2021 (published online Apr 22)

Kalkowska DA, Voorman A, Pallansch MA, et al. The impact of disruptions caused by the COVID-19 pandemic on global polio eradication. Vaccine 2021 (published online Apr 27)

Lickness JS, Gardner T, Diop OM, et al. Surveillance to track progress toward polio eradication—worldwide, 2018-2019. MMWR 2020 May 22;69(20):623-9

Mansour Z, Said R, Wannamuehler K, et al. Estimating population immunity to poliovirus in Lebanon: results from a seroprevalence survey, 2016. Vaccine 2020 (published online Jun 1)

Martinez M, Akbar IE, Wadood MZ, et al. Progress toward poliomyelitis eradication—Afghanistan, January 2019–July 2020. MMWR 2020 Oct 9;69(40):1464-8

Mashunye T, Ndwandwe DE, Dube KR, et al. Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis. Lancet Infect Dis 2021 (published online Apr 30)

Moffett DB, Llewellyn A, Singh H, et al. Progress toward poliovirus containment implementation—worldwide, 2019-2020. MMWR Sep 18;69(37):1330-3

Saez-Llorens X, Bandyopadhyay AS, Gast C, et al. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials. Lancet 2020 (published online Dec 9)

Saleem AF, Mach O, Yousafzai MT, et al. One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine. J Infect Dis 2020 (published online Aug 15)

Tagbo BN, Verma H, Mahmud ZM, et al. Randomized controlled clinical trial of bivalent oral poliovirus vaccine and inactivated poliovirus vaccine in Nigerian children. J Infect Dis 2020 (published online Nov 24)

Tagbo BN, Verma H, Mahmud ZM, et al. Randomized controlled clinical trial of bivalent oral poliovirus vaccine and inactivated poliovirus vaccine in Nigerian children. J Infect Dis 2020 (published online Nov 24)

Tuma JN, Wilkinson AL, Diop OM, et al. Surveillance to track progress toward polio eradication—worldwide, 2019-2020. MMWR 2021 May 7;70(2):667-73

Yan S, Chen J, Zhang Z, et al. Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: a randomized, controlled, open-label, phase IV clinical trial in China. Vaccine 2020 (published online Jul 31)

Zomahoun DJ, Burman AL, Snider CJ, et al. Impact of COVID-19 pandemic on global poliovirus surveillance. MMWR Jan 1;69(5152):1648-52

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»